Drug-induced hypoglycaemia: an update
- PMID: 20942513
- DOI: 10.2165/11538290-000000000-00000
Drug-induced hypoglycaemia: an update
Abstract
Drugs are the most frequent cause of hypoglycaemia in adults. Although hypoglycaemia is a well known adverse effect of antidiabetic agents, it may occasionally develop in the course of treatment with drugs used in everyday clinical practice, including NSAIDs, analgesics, antibacterials, antimalarials, antiarrhythmics, antidepressants and other miscellaneous agents. They induce hypoglycaemia by stimulating insulin release, reducing insulin clearance or interfering with glucose metabolism. Several drugs may also potentiate the hypoglycaemic effect of antidiabetic agents. Administration of these agents to individuals with diabetes mellitus is of most concern. Many of these drugs, and depending on clinical setting, may also induce hyperglycaemia. Drug-induced hepatotoxicity and nephrotoxicity may lead in certain circumstances to hypoglycaemia. Some drugs may also induce hypoglycaemia by causing pancreatitis. Drug-induced hypoglycaemia is usually mild but may be severe. Effective clinical management can be handled through awareness of this drug-induced adverse effect on blood glucose levels. Herein, we review pertinent clinical information on the incidence of drug-induced hypoglycaemia and discuss the underlying pathophysiological mechanisms, and prevention and management.
Similar articles
-
Drug-induced disorders of glucose metabolism. Mechanisms and management.Drug Saf. 1996 Aug;15(2):135-57. doi: 10.2165/00002018-199615020-00005. Drug Saf. 1996. PMID: 8884164 Review.
-
Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.Nat Rev Endocrinol. 2014 Dec;10(12):711-22. doi: 10.1038/nrendo.2014.170. Epub 2014 Oct 7. Nat Rev Endocrinol. 2014. PMID: 25287289 Review.
-
Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes?Int J Obes Relat Metab Disord. 2000 Sep;24 Suppl 3:S21-31. doi: 10.1038/sj.ijo.0801422. Int J Obes Relat Metab Disord. 2000. PMID: 11063281 Review.
-
Modified release terbutaline (SKP1052) for hypoglycaemia prevention: a proof-of-concept study in people with type 1 diabetes mellitus.Diabetes Obes Metab. 2012 Dec;14(12):1137-44. doi: 10.1111/dom.12003. Epub 2012 Sep 25. Diabetes Obes Metab. 2012. PMID: 22988932 Clinical Trial.
-
[Hypoglycemia--a dreaded complication of diabetes].Tidsskr Nor Laegeforen. 2000 Aug 30;120(20):2441-4. Tidsskr Nor Laegeforen. 2000. PMID: 11475234 Review. Norwegian.
Cited by
-
Interpreting adverse signals in diabetes drug development programs.Diabetes Care. 2013 Jul;36(7):2098-106. doi: 10.2337/dc13-0182. Epub 2013 May 21. Diabetes Care. 2013. PMID: 23695817 Free PMC article. Review.
-
Pharmacological mechanisms of norcantharidin against hepatocellular carcinoma.Am J Cancer Res. 2023 Nov 15;13(11):5024-5038. eCollection 2023. Am J Cancer Res. 2023. PMID: 38058814 Free PMC article. Review.
-
Drug-induced hyperinsulinemic hypoglycemia: An update on pathophysiology and treatment.Rev Endocr Metab Disord. 2023 Dec;24(6):1031-1044. doi: 10.1007/s11154-023-09828-y. Epub 2023 Aug 8. Rev Endocr Metab Disord. 2023. PMID: 37552352 Review.
-
Sulfasalazine-Induced Hypoglycemia in a Patient with Type 2 Diabetes and End-Stage Renal Disease.AACE Clin Case Rep. 2020 Dec 8;4(6):e493-e496. doi: 10.4158/ACCR-2018-0067. eCollection 2018 Nov-Dec. AACE Clin Case Rep. 2020. PMID: 40786848 Free PMC article.
-
Hypoglycemia in non-diabetic in-patients: clinical or criminal?PLoS One. 2012;7(7):e40384. doi: 10.1371/journal.pone.0040384. Epub 2012 Jul 2. PLoS One. 2012. PMID: 22768352 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical